The chemical substance known as sodium (3R,5R)-7-[2-(4-fluorophenyl)-4-[(2-hydroxyphenyl)carbamoyl]-3-phenyl-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate, with the CAS number 163217-75-2, is a complex organic compound characterized by its multi-functional structure. It features a pyrrolidine ring, which contributes to its potential biological activity, and multiple hydroxyl groups that enhance its solubility and reactivity. The presence of a fluorophenyl group suggests potential interactions with biological targets, making it of interest in medicinal chemistry. The compound's sodium salt form indicates enhanced solubility in aqueous environments, which is advantageous for pharmacological applications. Its stereochemistry, denoted by the (3R,5R) configuration, implies specific spatial arrangements that can influence its biological interactions and efficacy. Overall, this compound's intricate structure and functional groups suggest potential utility in therapeutic contexts, particularly in drug development, although specific biological activities would require further investigation.

sodium:(3R,5R)-7-[2-(4-fluorophenyl)-4-[(2-hydroxyphenyl)carbamoyl]-3-phenyl-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate

163217-75-2: The chemical substance known as sodium (3R,5R)-7-[2-(4-fluorophenyl)-4-[(2-hydroxyphenyl)carbamoyl]-3-phenyl-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate, with the CAS number 163217-75-2, is a complex organic compound characterized by its multi-functional structure. It features a pyrrolidine ring, which contributes to its potential biological activity, and multiple hydroxyl groups that enhance its solubility and reactivity. The presence of a fluorophenyl group suggests potential interactions with biological targets, making it of interest in medicinal chemistry. The compound's sodium salt form indicates enhanced solubility in aqueous environments, which is advantageous for pharmacological applications. Its stereochemistry, denoted by the (3R,5R) configuration, implies specific spatial arrangements that can influence its biological interactions and efficacy. Overall, this compound's intricate structure and functional groups suggest potential utility in therapeutic contexts, particularly in drug development, although specific biological activities would require further investigation.

CAS 163217-75-2

sodium:(3R,5R)-7-[2-(4-fluorophenyl)-4-[(2-hydroxyphenyl)carbamoyl]-3-phenyl-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate

Atorvastatin 2-Hydroxy Analog

Ref: ST-EA-CP-A32053